Education
About Us
Working with TipRanks
Follow Us
Mark Diamond Insider Profile
4 Followers
Mark Diamond, Managing Director at Percheron Therapeutics, holds 4.89M shares in Percheron Therapeutics (Ticker: PERCF). Most recently, Mark Diamond Bought 263,158 shares of Percheron Therapeutics on Feb 13, 2017 for an estimated value of $10.00K.
Mark Diamond Percheron Therapeutics (PERCF)Managing Director
Percheron Therapeutics (PERCF)
Managing Director
Ranked #81,830 out of 105,819 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-26.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Managing Director
Roles that Mark Diamond holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 13, 2017 - Feb 13, 2018
Return:0.00%
The most profitable trade made by Mark Diamond
Mark Diamond's Trading History
List of latest transactions for each holding click on a transaction to see Mark Diamond's performance on stock
You May Also Like
Mark Diamond insider profile FAQ
What is the percentage of profitable transactions made by Mark Diamond?
The percentage of profitable transactions made by Mark Diamond is 0%.
What is the average return per transaction made by Mark Diamond?
The average return per transaction made by Mark Diamond is -26.40%.
What stocks does Mark Diamond hold?
Mark Diamond holds: PERCF stocks.
What was Mark Diamond’s latest transaction?
Mark Diamond latest transaction was an Informative Buy of $10.00K.
What was Mark Diamond's most profitable transaction?
Mark Diamond’s most profitable transaction was an Informative Buy of PERCF stock on February 13, 2017. The return on the trade was 0.00%.
What is Mark Diamond's role in Percheron Therapeutics?
Mark Diamond's role in Percheron Therapeutics is Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.